-
Developing the next generation of treatments requires multinational co-operation and co-ordination. Bronchiectasis has historically been a neglected "Orphan" disease. An international network will build capacity to perform high impact clinical trials and observational studies in bronchiectasis
-
The European Bronchiectasis Registry is supported by the European Union Innovative Medicines Initiative under the "New Drugs for Bad Bugs" programme, to help facilitate the development of new antibiotics against Gram-negative infections
-
A sub-study gathering data on patients with pulmonary NTM disease has been created and linked to the European bronchiectasis registry. Help us reach the target of 1000 patients!
-
EMBARC work closely with the European Lung Foundation to promote patient priorities and improve patient education and resources.
-
The largest bronchiectasis biobanking study is underway and will gather in depth data on cilia, inflammatory markers and many more clinical measures linked to the registry.
-
Advancing research and improving clinical care for patients with non-cystic fibrosis bronchiectasis
-
EMBARC promotes awareness and clinical excellence in bronchiectasis care through educational events, courses and online resources.
-
EMBARC works with the European Respiratory Society and the national societies and networks around the world to promote co-operation, data sharing and clinical research in bronchiectasis
-
EMBARC is a European Respiratory Society clinical research collaboration, dedicated to encouraging participation from young and experienced researchers around Europe in the field of bronchiectasis
EMBARC is a pan-European network committed to promoting clinical research and education in bronchiectasis, through sharing of protocols, research idea and expertise. Central to this project is the creation of the European Bronchiectasis Registry, a collaboration open to all investigators around Europe caring for patients with bronchiectasis.
Latest News
Findings from the non-tuberculous mycobacterial (NTM) lung infections patient survey 2020
Find out more about what people told us were the challenges of being tested and treated for non-tuberculous mycobacteria disease (NTM-PD) in the report of our survey findings.
https://www. …
Read More**UPDATE** 4th World Bronchiectasis & NTM Conference
The 4th World Bronchiectasis & NTM Conference is going virtual! Join us on the 16th – 19th December 2020.
Deadline for abstracts submission has closed but a final chance …
Read MoreEMBARC COVID19 substudy now open – invitation to participate
Due to the recent COVID-19 outbreak, it is extremely important we collect as much information about how this infection affects our bronchiectasis patients. We have therefore initiated data collection …
Read MoreLatest Research
Bronchiectasis insanity: Doing the same thing over and over again and expecting different results?
New Insights Into the Epidemiology of Bronchiectasis.
Medical management of bronchiectasis.
Recruitment
Join EMBARC
EMBARC is an open group and free to join.
For more information contact info@bronchiectasis.eu
Sign up at the registration page
| Talk to us on Twitter! |  |
| Connect with us on LinkedIn |  |
 |
EMBARC AT ERS 2015
